Institutional Cluster

ORKA

Oruka Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed3mo ago
Institutional cluster: 5 buyers, 1 sellers (bullish)
Actionable Insight • Neutral

The cluster is dominated by passive rebalancing, not active conviction. Monitor next 13F filing for active fund entries or exits. The 95% analyst bullish consensus and $3.9B market cap suggest the stock is well-covered but this filing provides no new catalyst signal.

DirectionNeutral
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
ORKA ▲ +35.11% at T+60d
NEUTRAL call ✓ call won +35.11% · α vs SPY +30.71% · entry $68.47 → $92.51
Entry anchored
Jun 11, 04:35 AM ET
via exchange tick
T+1d
+2.07%
call +2.07% · α +1.53%
$69.89
settled 4mo ago
T+5d
+3.52%
call +3.52% · α +3.09%
$70.88
settled 4mo ago
T+20d
+28.92%
call +28.92% · α +27.03%
$88.27
settled 3mo ago
T+60d
+35.11%
call +35.11% · α +30.71%
$92.51
settled 24d ago

Executive Summary

Five mega-passive institutional investors (State Street, Fidelity, T. Rowe Price, Schwab, BofA) increased their ORKA holdings by a net $90.1M in Q3 2025, while only Morgan Stanley trimmed a small position. The buying is dominated by passive/index fund managers, suggesting index rebalancing or passive inflows rather than an active investment thesis. The cluster is directionally bullish but lacks conviction from active managers.

Key Financial Metrics

Direction
accumulating
Buy Value
$158.4M
Sell Value
$2.6M
Net Flow
$90.1M

Institutional Positions

Net institutional flow: $90.1M

▲ Buyers (5)

InstitutionActionChangePosition ValueValue Δ
State StreetADD+74.9%$12.5M$8.4M
FidelityADD+29.2%$139.6M$76.6M
T. Rowe PriceADD+52.6%$12.0K$7.0K
SchwabDOUBLED+194%$4.7M$3.8M
BofADOUBLED+319.1%$1.5M$1.3M

▼ Sellers (1)

InstitutionActionChangePrev ValueValue Δ
Morgan StanleyTRIM-35.3%$2.3M$257.0K

Key Facts

  • 5 buyers added $90.1M net; 1 seller trimmed $257K
  • All 5 buyers are mega-passive managers (State Street, Fidelity, T. Rowe Price, Schwab, BofA)
  • Fidelity alone added $76.6M, representing 85% of total buying
  • Morgan Stanley trimmed 35.3% of its position but its value rose $257K due to stock appreciation
  • No active hedge funds, activists, or family offices participated in the cluster

Financial Impact

Net institutional buying of $90.1M, with Fidelity contributing $76.6M of that total. Total buyer holdings now $158.4M.

institutional ownershipfloat

Risk Factors

  • Passive buying may reverse if ORKA is removed from an index or if passive flows rotate out of small/mid-cap pharma
  • No active manager participation means no informed catalyst thesis to follow
  • Historical calibration shows score-6/7/8 reports on ORKA have negative net alpha at T+20

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-ORKA-2025-Q3
26 reports for ORKA
Performance horizon
100% Hit rate 11 of 11 directional calls best @ T+60▲ +80.05%Jun 1, 2026
Filters
Rows
Reports for ORKA — sortable, filterable
TypeNow
Sep 15, 2026
16d ago
Insider Cluster
NEUTRAL ★ 3/10
$93.55 $89.93▼ −3.87%▼ −6.44%—
Sep 1, 2026
4w ago
Insider Cluster
BEARISH ★ 4/10
$91.63 $91.65▼ −0.02%▼ −0.98%—
Aug 28, 2026
5w ago
EFFECT
BEARISH ★ 6/10
$91.15 $92.51▼ −1.50%▼ −1.39%—
Aug 17, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$113.08 $101.82▼ −9.96%▼ −9.76%—
Aug 10, 2026
7w ago
Press Release
BULLISH ★ 7/10
$105.14 $112.66▲ +7.15%▲ +7.20%—
Aug 10, 2026
7w ago
8-K
BULLISH ★ 6/10
$105.14 $112.66▲ +7.15%▲ +7.20%—
Aug 9, 2026
7w ago
Institutional Cluster
BULLISH ★ 7/10
$105.14 $112.66▲ +7.15%▲ +7.20%—
Jul 15, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$83.04 $91.95▲ +10.73%▲ +12.40%—
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 5/10
$85.21 $88.27▲ +3.59%▲ +2.66%—
Jun 22, 2026
14w ago
Insider Cluster
NEUTRAL ★ 3/10
$83.40 $92.49▲ +10.90%▲ +9.89%—
Showing 10 of 26

US Market Status

Market Open — Closes in 3h 51m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 11, 2026